Altimmune Cash Conversion Cycle 2011-2026 | ALT

Annual Cash Conversion Cycle Altimmune

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15.1 K	550	-464	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.1 K	-464	5.06 K

Quarterly Cash Conversion Cycle Altimmune

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
10.6 K	7.56 K	9.59 K	-	7.77 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	152	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10.6 K	15	5.95 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	-400	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	123	$ 33.23	-4.03 %	$ 584 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	115	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	173	$ 3.72	-2.75 %	$ 1.11 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	-123	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	-256	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	-114	$ 64.66	-1.37 %	$ 12.4 B	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Certara CERT	81.8	$ 7.16	1.49 %	$ 1.15 B	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Catalyst Pharmaceuticals CPRX	120	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Codexis CDXS	-48.2	$ 0.99	-3.28 %	$ 72.7 M	USA
CTI BioPharma Corp. CTIC	-216	-	-	$ 1.2 B	USA
Cyclacel Pharmaceuticals CYCC	-1.6 K	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	-1.6 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	-101	-	-	$ 2.18 B	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	1.89	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Eton Pharmaceuticals ETON	-6.66	$ 17.54	-3.36 %	$ 450 M	USA
Evofem Biosciences EVFM	-630	-	7.55 %	$ 38.1 M	USA